Clinical Trial Detail

NCT ID NCT03506048
Title Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Emory University
Indications

thyroid gland cancer

Therapies

Lenvatinib

Age Groups: adult senior

No variant requirements are available.